The Food and Drug Administration today announced a public-private partnership to advance COVID-19 diagnostics.

“While there are current studies of viral diagnostic and antibody tests using traditional assessment methods, the Diagnostics Evidence Accelerator will allow the community to analyze both diagnostic and clinical data in real time, which has the potential to contribute to the scientific evaluation of diagnostic tools and medical interventions for COVID-19,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D.

The project is a companion to a Therapeutic Evidence Accelerator launched by the Udall Foundation for the FDA and Friends of Cancer Research in April, which brings together experts in health data aggregation and analytics to inform the collective COVID-19 response.

In other COVID-19 news this week, FDA approved a new drug to facilitate tracheal intubation and muscle relaxation during surgery or mechanical ventilation; and issued warning letters to three companies for marketing unauthorized test kits directly to consumers for at-home use.

Related News Articles

Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…